ethyl 2-(4-(6-fluoroindolin-1-yl)piperidine-1-carboxamido)thiazole-4-carboxylate | 1443247-84-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: ethyl 2-(4-(6-fluoroindolin-1-yl)piperidine-1-carboxamido)thiazole-4-carboxylate
• 英文别名: Ethyl 2-(4-(6-fluoroindolin-1-yl)piperidine-1-carboxamido)thiazole-4-carboxylate；ethyl 2-[[4-(6-fluoro-2,3-dihydroindol-1-yl)piperidine-1-carbonyl]amino]-1,3-thiazole-4-carboxylate
• CAS: 1443247-84-4
• 化学式: C₂₀H₂₃FN₄O₃S
• 分子量: 418.492
• InChiKey: HSEXIOBRLKPNTB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  29
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  103
• 氢给体数：
  1
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  ethyl 2-(4-(6-fluoroindolin-1-yl)piperidine-1-carboxamido)thiazole-4-carboxylate 在 甲胺 作用下， 以 乙醇 、 水 为溶剂， 反应 48.0h， 生成 2-(4-(6-fluoroindolin-1-yl)piperidine-1-carboxamido)-N-methylthiazole-4-carboxamide
  参考文献：
  名称：

  4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable Stearoyl-CoA desaturase-1 (SCD1) inhibitors. Part 1: Urea-based analogs

  摘要：

  A new series of urea-based, 4-bicyclic heteroaryl-piperidine derivatives as potent SCD1 inhibitors is described. The structure-activity relationships focused on bicyclic heteroarenes and aminothiazole-urea portions are discussed. A trend of dose-dependent decrease in body weight gain in diet-induced obese (DIO) mice is also demonstrated. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2013.09.096
• 作为产物：
  描述：

  2-氨基噻唑-4-甲酸乙酯 在 吡啶 、 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 3.5h， 生成 ethyl 2-(4-(6-fluoroindolin-1-yl)piperidine-1-carboxamido)thiazole-4-carboxylate
  参考文献：
  名称：

  4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable Stearoyl-CoA desaturase-1 (SCD1) inhibitors. Part 1: Urea-based analogs

  摘要：

  A new series of urea-based, 4-bicyclic heteroaryl-piperidine derivatives as potent SCD1 inhibitors is described. The structure-activity relationships focused on bicyclic heteroarenes and aminothiazole-urea portions are discussed. A trend of dose-dependent decrease in body weight gain in diet-induced obese (DIO) mice is also demonstrated. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2013.09.096

文献信息

• [EN] SUBSTITUTED PIPERIDINYL-CARBOXAMIDE DERIVATIVES USEFUL AS SCD 1 INHIBITORS<br/>[FR] DÉRIVÉS DE PIPÉRIDINYL-CARBOXAMIDE SUBSTITUÉ UTILES EN TANT QU'INHIBITEURS DE SCD 1
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2013085954A1

  公开（公告）日：2013-06-13

  The present invention is directed to novel piperidinyl-carboxamide derivatives, pharmaceutical compositions containing them and their use as inhibitors of SCD1, useful in the treatment of obesity, type-II diabetes and other related metabolic disorders.

  本发明涉及新型哌啶基-羧酰胺衍生物、含有它们的制药组合物以及它们作为SCD1抑制剂的用途，适用于治疗肥胖症、2型糖尿病和其他相关代谢性疾病。
• SUBSTITUTED PIPERIDINYL-CARBOXAMIDE DERIVATIVES USEFUL AS SCD 1 INHIBITORS
  申请人：Janssen Pharmaceutica NV

  公开号：US20140364393A1

  公开（公告）日：2014-12-11

  The present invention is directed to novel piperidinyl-carboxamide derivatives, pharmaceutical compositions containing them and their use as inhibitors of SCD1, useful in the treatment of obesity, type-II diabetes and other related metabolic disorders.

  本发明涉及新型哌啶基-羧酰胺衍生物、包含它们的制药组合物以及它们作为SCD1抑制剂的用途，用于治疗肥胖症、2型糖尿病和其他相关代谢性疾病。
• Substituted piperidinyl-carboxamide derivatives useful as SCD 1 inhibitors
  申请人：Janssen Pharmaceutica NV

  公开号：US09238658B2

  公开（公告）日：2016-01-19

  The present invention is directed to novel piperidinyl-carboxamide derivatives, pharmaceutical compositions containing them and their use as inhibitors of SCD1, useful in the treatment of obesity, type-II diabetes and other related metabolic disorders.

  本发明涉及一种新的哌啶基-羧酰胺衍生物，包括含有它们的制药组合物以及它们作为SCD1抑制剂的用途，对于治疗肥胖症、2型糖尿病和其他相关代谢性疾病有用。
• US9238658B2
  申请人：——

  公开号：US9238658B2

  公开（公告）日：2016-01-19
• 4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable Stearoyl-CoA desaturase-1 (SCD1) inhibitors. Part 1: Urea-based analogs
  作者：Shyh-Ming Yang、Yuting Tang、Rui Zhang、Huajun Lu、Gee-Hong Kuo、Michael D. Gaul、Yaxin Li、George Ho、James G. Conway、Yin Liang、James M. Lenhard、Keith T. Demarest、William V. Murray

  DOI：10.1016/j.bmcl.2013.09.096

  日期：2013.12

  A new series of urea-based, 4-bicyclic heteroaryl-piperidine derivatives as potent SCD1 inhibitors is described. The structure-activity relationships focused on bicyclic heteroarenes and aminothiazole-urea portions are discussed. A trend of dose-dependent decrease in body weight gain in diet-induced obese (DIO) mice is also demonstrated. (C) 2013 Elsevier Ltd. All rights reserved.